Financials EKF Diagnostics Holdings plc
Equities
EKF
GB0031509804
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
29.30 GBX | +2.63% | +5.02% | -7.42% |
Projected Income Statement: EKF Diagnostics Holdings plc
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 44.92 | 65.26 | 81.84 | 66.64 | 52.61 | 54.51 | 58.65 | 63.59 |
Change | - | 45.29% | 25.4% | -18.57% | -21.05% | 3.62% | 7.58% | 8.42% |
EBITDA 1 | 12 | 25.52 | 26.49 | 14.9 | 10.38 | 11.69 | 13.85 | 16.78 |
Change | - | 112.54% | 3.81% | -43.74% | -30.33% | 12.55% | 18.48% | 21.17% |
EBIT 1 | 8.375 | 18.38 | 25.69 | 12.11 | 7.11 | 6.987 | 8.848 | 11.92 |
Change | - | 119.46% | 39.75% | -52.84% | -41.31% | -1.72% | 26.63% | 34.72% |
Interest Paid | -0.266 | -1.539 | -0.312 | -0.102 | -0.075 | - | - | - |
Earnings before Tax (EBT) 1 | - | 15.36 | 21.44 | -8.942 | 2.131 | 8.285 | 10.78 | 13.59 |
Change | - | - | 39.59% | - | - | 288.8% | 30.16% | 26.04% |
Net income | - | 11.11 | 15.85 | -10.1 | 2.352 | - | - | - |
Change | - | - | 42.62% | - | - | -100% | - | - |
Announcement Date | 07/04/20 | 30/03/21 | 29/03/22 | 28/03/23 | 20/03/24 | - | - | - |
Forecast Balance Sheet: EKF Diagnostics Holdings plc
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | -10.4 | -20.3 | -19.6 | -11.4 | -3.63 | -11 | -17.4 | -25.3 |
Change | - | -295.19% | -196.55% | -158.16% | -131.84% | -403.28% | -258.18% | -245.4% |
Announcement Date | 07/04/20 | 30/03/21 | 29/03/22 | 28/03/23 | 20/03/24 | - | - | - |
Cash Flow Forecast: EKF Diagnostics Holdings plc
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
CAPEX 1 | 1.418 | 1.631 | 4.335 | 4.434 | 6.598 | 3.15 | 3 | 3.15 |
Change | - | 15.02% | 165.79% | 2.28% | 48.8% | -52.26% | -4.76% | 5% |
Free Cash Flow (FCF) 1 | - | 12.18 | 5.903 | 3.86 | -0.664 | 6.966 | 7.193 | 8.715 |
Change | - | - | -51.53% | -34.61% | -117.2% | -1,149.06% | 3.27% | 21.15% |
Announcement Date | 07/04/20 | 30/03/21 | 29/03/22 | 28/03/23 | 20/03/24 | - | - | - |
Forecast Financial Ratios: EKF Diagnostics Holdings plc
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|---|
Profitability | |||||||||
EBITDA Margin (%) | - | 26.73% | 39.1% | 32.37% | 22.37% | 19.74% | 21.44% | 23.61% | 26.39% |
EBIT Margin (%) | - | 18.65% | 28.16% | 31.39% | 18.18% | 13.51% | 12.82% | 15.09% | 18.75% |
EBT Margin (%) | - | - | 23.53% | 26.19% | -13.42% | 4.05% | 15.2% | 18.39% | 21.38% |
Net margin (%) | - | - | 17.03% | 19.37% | -15.16% | 4.47% | - | - | - |
FCF margin (%) | - | - | 18.66% | 7.21% | 5.79% | -1.26% | 12.78% | 12.27% | 13.71% |
FCF / Net Income (%) | - | - | 109.57% | 37.24% | -38.21% | -28.23% | - | - | - |
Profitability | |||||||||
ROA | 4.53% | 4.04% | 10.36% | 12.62% | 5.23% | 3.61% | - | - | - |
ROE | 16.56% | 5.82% | 15.24% | 18.69% | -11.31% | 3.83% | - | - | - |
Financial Health | |||||||||
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - | - |
Debt / Free cash flow | - | - | - | - | - | - | - | - | - |
Capital Intensity | |||||||||
CAPEX / Current Assets (%) | - | 3.16% | 2.5% | 5.3% | 6.65% | 12.54% | 5.78% | 5.12% | 4.95% |
CAPEX / EBITDA (%) | - | 11.81% | 6.39% | 16.37% | 29.75% | 63.54% | 26.95% | 21.67% | 18.77% |
CAPEX / FCF (%) | - | - | 13.39% | 73.44% | 114.87% | -993.67% | 45.22% | 41.71% | 36.14% |
Items per share | |||||||||
Cash flow per share 1 | - | 0.0111 | 0.0301 | 0.0222 | 0.0212 | 0.0139 | - | - | - |
Change | - | - | 170.44% | -26.21% | -4.59% | -34.4% | - | - | - |
Dividend per Share 1 | - | 0.01 | 0.011 | 0.012 | 0.012 | 0.012 | - | - | - |
Change | - | - | 10% | 9.09% | 0% | 0% | - | - | - |
Book Value Per Share 1 | - | 0.154 | 0.17 | 0.206 | 0.1612 | - | 0.1512 | 0.1512 | 0.1528 |
Change | - | - | 10.43% | 21.18% | -21.74% | - | - | -0.02% | 1.08% |
EPS 1 | - | - | 0.0242 | 0.0344 | -0.0221 | 0.0052 | - | - | - |
Change | - | - | - | 42.15% | -164.24% | -123.53% | - | - | - |
Nbr of stocks (in thousands) | - | 454,093 | 454,993 | 463,931 | 454,931 | 453,731 | 453,731 | 453,731 | 453,731 |
Announcement Date | - | 07/04/20 | 30/03/21 | 29/03/22 | 28/03/23 | 20/03/24 | - | - | - |
2024 * | 2025 * | |
---|---|---|
P/E ratio | - | - |
PBR | 1.89x | 1.89x |
EV / Sales | 2.17x | 1.91x |
Yield | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
- Stock Market
- Equities
- EKF Stock
- Financials EKF Diagnostics Holdings plc
MarketScreener is also available in this country: United States.
Switch edition